Table 3.

Comparison of recipients who experienced graft fibrosis at a fast (greater than 0.8 fibrosis units per year) or slow (less than 0.8 units per year) rate

	Slow fibrosis (<0.8 units/year)	Fast fibrosis (>0.8 units/year)	Univariate analysis	Multivariate analysis
n	29	27
Recipient age (y)	50 (34–67)	46 (28–65)	0.3	0.7
Recipient sex (M/F)	24/5	21/6	0.6	0.8
Caucasian	15	14	0.4	0.5
Cyclosporin/tacrolimus	26/3	23/4	0.6	0.4
Treated rejection	10	11	0.6	0.12
>1 episode rejection	3	0	0.2	0.8
HBsAg positive*	3	2	0.7	0.5
Cold ischaemic time (min)	787 (261–1280)	780 (353–1055)	0.7	0.4
Warm ischaemic time (min)	44 (25–58)	51 (33–76)	0.02	0.01
Donor sex (M/F)	18/11	20/7	0.34	0.34
Donor age (y)	38 (15–64)	45 (17–67)	0.09	0.02
Date of transplantation (pre/post 11/96)	16/13	12/15	0.42	0.96

HBsAg, hepatitis B virus surface antigen.

*Serum status pre-transplant—all were serum HBsAg negative post-transplant.

Data are median (range).